Tadalafil for womb lining thickness in women having frozen embryo transfer for infertility
Tests tadalafil in women with unexplained infertility undergoing IVF with frozen embryos.
Key facts
- Who runs it
- Beni-Suef University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 100 people, planned
- Started
- 1 Oct 2023
- Planned end
- 30 Apr 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Tadalafil 5mg
- estradiol valerate 2 mg
- Record updated
- 30 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with unexplained infertility having IVF who have good quality day five frozen embryos. It tests whether Tadalafil helps the womb lining and frozen embryo transfer.
- Age
- 18 Years to 43 Years
- Sex
- Female only
- Disease stage
- Unexplained infertility, using IVF with frozen embryo transfer.
- Earlier treatment
- Must already have good quality day five frozen embryos.
Main reasons for not taking part
- Low blood pressure (less than 90/50)
- History of stroke
- History of heart attack (myocardial infarction)
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- has good quality day five frozen embryos
Who cannot take part
- history of stroke or myocardial infarction
- hypotension (blood pressure less than 90/50) and
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 43 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
investigate the effect of different vasodilators as Tadalafil in women with unexplained infertility using IVF
The 2 groups in the trial
- (control)Existing treatment, for comparison
Patients received estradiol valerate 2 mg. in form of (Cycloprogynova® Bayer Shering Pharma) white pills starting dose is one pill T.I.D may be increased to two pills T.I.D according to endometrial thickness in day 9 measured by vaginal ultrasound.
Treatment: estradiol valerate 2 mg
- tadalafil 5 mgTreatment being tested
once daily in form of (tadanerfi 5® Nerhadou international5 co.) daily in addition to the above treatment protocol from the first day of the cycle until the day of starting progesterone
Treatment: Tadalafil 5mg
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes
- Plain-language title
- Tadalafil for womb lining thickness in women having frozen embryo transfer for infertilityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Fit questions
- Built from NCT07499804, who can take part
- Record updated
- 30 March 2026